ABSTRACT
Organismal aging entails a gradual decline of normal physiological functions and a major contributor to this decline is withdrawal of the cell cycle, known as senescence. Senescence can result from telomere diminution leading to a finite number of population doublings, known as replicative senescence (RS), or from oncogene overexpression, as a protective mechanism against cancer. Senescence is associated with large-scale chromatin re-organization and changes in gene expression. Replication stress is a complex phenomenon, defined as the slowing or stalling of replication fork progression and/or DNA synthesis, which has serious implications for genome stability, and consequently in human diseases. Aberrant replication fork structures activate the replication stress response leading to the activation of dormant origins, which is thought to be a safeguard mechanism to complete DNA replication on time. However, the relationship between replicative stress and the changes in the spatiotemporal program of DNA replication in senescence progression remains unclear.
Here, we studied the DNA replication program during senescence progression in proliferative and pre-senescent cells from donors of various ages by single DNA fiber combing of replicated DNA, origin mapping by sequencing short nascent strands and genome-wide profiling of replication timing (TRT).
We demonstrate that, progression into RS leads to reduced replication fork rates and activation of dormant origins, which are the hallmarks of replication stress. However, with the exception of a delay in RT of the CREB5 gene in all pre-senescent cells, RT was globally unaffected by replication stress during entry into either oncogene-induced or RS. Consequently, we conclude that RT alterations associated with physiological and accelerated aging, do not result from senescence progression. Our results clarify the interplay between senescence, aging and replication programs and demonstrate that RT is largely resistant to replication stress.
Acknowledgments
We thank Ruth A. Didier for assistance with flow cytometry and Julian Venables and Armando Aranda-Anzaldo for critical reading of the manuscript. This work has been supported by French Ministery of Research, the CNRS, the “Région Languedoc Roussillon” la Ligue Nationale Contre le Cancer Grant “Programme Labellisation Equipe 2015 (EL2015.LNCC/JML) and for Ph.D. student Fellowship for EB and HS (to JML). This work was also supported by NIH Grants GM083337 and GM085354 (to D.M.G.). We acknowledge the French National infrastructure on Pluripotent Stem Cell INGESTEM National Infrastructure in Biology and Health and the SAFE-iPSC stem cell core Facility of IRMB and CHU of Montpellier.
Disclosure statement
No potential conflict of interest was reported by the authors.
Supplementary material
Supplemental data for this article can be accessed here.
Additional information
Notes on contributors
David M. Gilbert
Conception and design: JML and JCRM; cell culture:, HS, JCRM, RD and CTG; DNA combing and short nascent strand sequencing: EB; RT datasets: JCRM, CTG and JS; data analysis and interpretation: JCRM, RD, PB, AZ and JML; manuscript writing: JCRM, JML and DMG